Atıf İçin Kopyala
Arbyn M., Simon M., de Sanjose S., Clarke M. A., Poljak M., Rezhake R., ...Daha Fazla
LANCET ONCOLOGY, cilt.23, sa.7, ss.950-960, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
23
Sayı:
7
-
Basım Tarihi:
2022
-
Doi Numarası:
10.1016/s1470-2045(22)00294-7
-
Dergi Adı:
LANCET ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.950-960
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-risk human papillomavirus (HPV) types, are more protective than cervical cytology. We systematically reviewed the literature to assess whether tests targeting high-risk HPV (hrHPV) mRNA are as accurate and effective as HPV DNA-based screening tests.